Disclosed are a brain tumor marker for use in the prediction of prognosis of a patient with brain tumor and use of the marker.

Furthermore, the causative protein thus identified is usable as, for example, a tumor marker.

Disclosed is a novel protein useful as a tumor marker for pancreatic cancer or a fragment of the protein.

Conventional diagnosis of liver cancer has been conducted by using as the tumor marker AFP, CEA or η-glutamyltranspeptidase.

It was used mostly as a shield to hide behind and throw out invective…

It is intended to provide a tumor marker by which poor prognosis cases can be distinguished from good prognosis cases at a high discrimination ratio among gastrointestinal stromal tumor cases.

AFP is considered a tumor marker because it suggests that cancer is present.

This method enables perfect early-stage detection of liver cancer by using UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminyl-transferase as the tumor marker.

If the tumor marker level in the blood goes down, it is almost always a sign that the treatment is working.

If tumor marker levels go down, it usually means the treatment is working.

It was developed as a tumor marker to screen for and to monitor prostate cancer.

If the tumor marker level declines, it usually is an indication that the current treatment is working.

tumor marker: Substance in blood or other body fluids that may suggest that a person has cancer.

tumor marker: Substance in blood or other body fluids that may suggest that a person has cancer.

Tumor marker: A substance in blood or other body fluids that may suggest that a person has cancer.